bioMérieux files FDA application for rapid vaginitis diagnostic panel

26 June 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Friday that it has submitted a Dual 510(k)/CLIA Waiver application to the US Food and Drug Administration ...